This is the authors' abstract. We don't add key points for this paper.
Abstract The Crimean-Congo hemorrhagic fever virus (CCHFV) causes Crimean-Congo hemorrhagic fever (CCHF), a widely distributed disease with significant morbidity and mortality. The virus has high genetic diversity correlated with geographic distribution, but limited temporal evolution within regions. Despite this, cases of CCHF within a region present as a spectrum of disease from often unrecognized asymptomatic infections to a severe, fatal viral hemorrhagic fever, suggesting host factors may play a role in disease outcome. We investigated the effect of host genetic diversity on the outcome of CCHFV infection in the genetically diverse Collaborative Cross mouse model. Infected mice recapitulated the full spectrum of disease recognized in humans and similar to human disease, virus replication, tissue pathology and inflammatory responses were associated with disease severity. Our study demonstrates that host genetics contribute to disease outcome in CCHF infection and establishes the Collaborative Cross mouse resource as a model to understand how host genetic diversity contributes to CCHF outcome.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: